Targeted controls in clinical immunohistochemistry - A useful approach to quality assurance

被引：12

作者：

Wick, MR ^{[1
]}

Swanson, PE

机构：

[1] Univ Virginia Hlth Syst, Div Surg Pathol, Charlottesville, VA 22903 USA

[2] Univ Washington, Med Ctr, Div Surg Pathol, Seattle, WA 98195 USA

来源：

AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2002年 / 117卷 / 01期

关键词：

D O I：

10.1309/7LQJ-LQQ0-JHYH-Y8U2

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：7 / 8

页数：2

共 10 条

[1] Mechanism of action of anti-HER2 monoclonal antibodies [J].

Baselga, J ;

Albanell, J .

ANNALS OF ONCOLOGY, 2001, 12 :35-41

[2]

Birner P, 2001, CLIN CANCER RES, V7, P1669

[3]

Field AS, 2001, PATHOLOGY, V33, P278

[4]

Pegram M, 2000, SEMIN ONCOL, V27, P13

[5]

Rhodes A, 2002, AM J CLIN PATHOL, V117, P81

[6] Current use of HER2 tests [J].

Schaller, G ;

Evers, K ;

Papadopoulos, S ;

Ebert, A ;

Bühler, H .

ANNALS OF ONCOLOGY, 2001, 12 :97-100

[7]

Swanson PE, 1999, AM J CLIN PATHOL, V111, P445

[8] HER2 - a discussion of testing approaches in the USA [J].

Thor, A .

ANNALS OF ONCOLOGY, 2001, 12 :101-107

[9] Pharmacology and therapeutic use of trastuzumab in breast cancer [J].

Treish, I ;

Schwartz, R ;

Lindley, C .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (22) :2063-2076

[10] Consensual interpretive guidelines for diagnostic immunohistochemistry [J].

Wick, MR ;

Mills, SE .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (09) :1208-1210

← 1 →